In silico Design and Computational Assessment of Small-Molecule GLP-1R Agonist as a Possible Treatment for Obesity and Type 2 Diabetes. Tikrit J. Pharm. Sci. [Internet]. 2026 Jun. 30 [cited 2026 Aug. 8];20(1):51-66. Available from: https://tjphs.tu.edu.iq/index.php/j/article/view/673